Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephanie E Combs

Showing results (161-170 of 594) with videos related to

Pageof 60
Sort By:
Radiation Oncology (London, England)|April 3, 2018
Influence of <sup>68</sup>Ga-DOTATOC on sparing of normal tissue for radiation therapy of skull base meningioma: differential impact of photon and proton radiotherapyFalk Stade, Jan-Oliver Dittmar, Oliver Jäkel, et al.
BMC Cancer|July 31, 2019
Have we achieved adequate recommendations for target volume definitions in anal cancer? A PET imaging based patterns of failure analysis in the context of established contouring guidelinesHendrik Dapper, Kilian Schiller, Stefan Münch, et al.
Journal of Neuro-Oncology|May 8, 2008
Radiochemotherapy with temozolomide as re-irradiation using high precision fractionated stereotactic radiotherapy (FSRT) in patients with recurrent gliomasStephanie E Combs, Marc Bischof, Thomas Welzel, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|December 8, 2018
CT-based dose recalculations in head and neck cancer radiotherapy: comparison of daily dose recalculations to less time-consuming approachesSimon Wagenblast, Severin Kampfer, Kai J Borm, et al.
International Journal of Radiation Oncology, Biology, Physics|June 5, 2007
In vitro responsiveness of glioma cell lines to multimodality treatment with radiotherapy, temozolomide, and epidermal growth factor receptor inhibition with cetuximabStephanie E Combs, Daniela Schulz-Ertner, Wilfried Roth, et al.
Tumori|August 20, 2009
Long-term outcome of postoperative irradiation in patients with newly diagnosed WHO grade III anaplastic gliomasMonika Nagy, Daniela Schulz-Ertner, Marc Bischof, et al.
Scientific Reports|March 16, 2022
Quality of life in patients treated with radiochemotherapy for primary diagnosis of anal cancerChristina Sauter, Jan C Peeken, Kai Borm, et al.
Reports of Practical Oncology and Radiotherapy : Journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology|June 14, 2019
Definitive, intensity modulated tomotherapy with a simultaneous integrated boost for prostate cancer patients - Long term data on toxicity and biochemical controlKilian Schiller, Michael Geier, Marciana Nona Duma, et al.
Radiation Oncology (London, England)|November 13, 2012
First experiences in treatment of low-grade glioma grade I and II with proton therapyHenrik Hauswald, Stefan Rieken, Swantje Ecker, et al.
Cancers|April 30, 2021
Excluding Lung Tissue from the PTV during Internal Mammary Irradiation. A Safe Technique for OAR-Sparing?Kai J Borm, Christopher Hofmann, Mathias Düsberg, et al.
Pageof 60

Showing results (161-170 of 594) with videos related to

Sort By:
Pageof 60
Radiation Oncology (London, England)|April 3, 2018
Influence of <sup>68</sup>Ga-DOTATOC on sparing of normal tissue for radiation therapy of skull base meningioma: differential impact of photon and proton radiotherapyFalk Stade, Jan-Oliver Dittmar, Oliver Jäkel, et al.
BMC Cancer|July 31, 2019
Have we achieved adequate recommendations for target volume definitions in anal cancer? A PET imaging based patterns of failure analysis in the context of established contouring guidelinesHendrik Dapper, Kilian Schiller, Stefan Münch, et al.
Journal of Neuro-Oncology|May 8, 2008
Radiochemotherapy with temozolomide as re-irradiation using high precision fractionated stereotactic radiotherapy (FSRT) in patients with recurrent gliomasStephanie E Combs, Marc Bischof, Thomas Welzel, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|December 8, 2018
CT-based dose recalculations in head and neck cancer radiotherapy: comparison of daily dose recalculations to less time-consuming approachesSimon Wagenblast, Severin Kampfer, Kai J Borm, et al.
International Journal of Radiation Oncology, Biology, Physics|June 5, 2007
In vitro responsiveness of glioma cell lines to multimodality treatment with radiotherapy, temozolomide, and epidermal growth factor receptor inhibition with cetuximabStephanie E Combs, Daniela Schulz-Ertner, Wilfried Roth, et al.
Tumori|August 20, 2009
Long-term outcome of postoperative irradiation in patients with newly diagnosed WHO grade III anaplastic gliomasMonika Nagy, Daniela Schulz-Ertner, Marc Bischof, et al.
Scientific Reports|March 16, 2022
Quality of life in patients treated with radiochemotherapy for primary diagnosis of anal cancerChristina Sauter, Jan C Peeken, Kai Borm, et al.
Reports of Practical Oncology and Radiotherapy : Journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology|June 14, 2019
Definitive, intensity modulated tomotherapy with a simultaneous integrated boost for prostate cancer patients - Long term data on toxicity and biochemical controlKilian Schiller, Michael Geier, Marciana Nona Duma, et al.
Radiation Oncology (London, England)|November 13, 2012
First experiences in treatment of low-grade glioma grade I and II with proton therapyHenrik Hauswald, Stefan Rieken, Swantje Ecker, et al.
Cancers|April 30, 2021
Excluding Lung Tissue from the PTV during Internal Mammary Irradiation. A Safe Technique for OAR-Sparing?Kai J Borm, Christopher Hofmann, Mathias Düsberg, et al.
Pageof 60